Vaccination against Mesothetioma using Combinant CM Vexmessing Tumour Antigents & the Development of Novel CMY constructs as Gene Therapy Vectors for Malingancy

    StatusFinished
    Effective start/end date1/01/0231/12/04

    Funding

    • Harry Perkins Institute of Medical Research (WAIMR)